[Aerosol thymopentin in the prevention of relapse of chronic bronchitis].
In this study the Authors have verified the efficacy of Thymopentin administered via aerosol in the prevention of recurrent catarrhal episodes in the patients affected by COPD during the winter season, compared to the previous winter. In October, 1 phial of Thymopentin was administered via aerosol to 15 patients affected by COPD, daily, for 10 consecutive days; all patients were evaluated at monthly clinical control for 4 months and all patients were invited to keep a diary of daily variations. After 4 months from treatment a net improvement was observed in the clinical parameters studied: sputum (volume and purulence), cough and dyspnoea, but the most interesting datum was the total absence of recurrent episodes of infection, associated to the reduction in quantity of antibiotics, mucolytics and number of days of illness and with noticeable improvement in the quality of life of the patients.
Chianese
R
R
Cattedra Malattie Apparato Respiratorio, Università di Bari.
Bilancia
R A
RA
Majorano
V
V
Ricatti
D G
DG
Cantacessi
G
G
Ricchiuto
G L
GL
Infantino
M P
MP
Gramiccioni
E
E
D000336:Aerosols; D000368:Aged; D001991:Bronchitis / Q000517:prevention & control*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D016305:Thymopentin / Q000627:therapeutic use*
D000336:Aerosols; D016305:Thymopentin
Timopentina per via aerosolica nella prevenzione delle riacutizzazioni della bronchite cronica.